Clinical Trial Update: Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial update on memantine's effects for sensorimotor gating and neurocognition in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: University of California, San Diego | Conditions: Schizophrenia, Schizo Affective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2022-12-21